Jamie L. Reynoso, the Chief Executive Officer of Clover Health Investments, has sold shares of the company's stock to cover tax obligations. This transaction, reported in a recent SEC filing, is part of a routine process associated with the vesting of restricted stock units.
The sale involved 18,273 shares of Class A Common Stock at a weighted average price of $4.68 per share. The transaction took place on October 15, 2026, and was necessary for Reynoso to meet tax withholding obligations stemming from the quarterly vesting of 6.25% of his restricted stock units, originally granted on October 15, 2024.
Background
Clover Health Investments, which trades under the symbol CLOV, operates in the hospital and medical service plans industry. The company is incorporated in Delaware and is known for its focus on Medicare Advantage plans. Clover Health has been navigating a competitive landscape in the healthcare sector, which is characterized by regulatory challenges and a need for innovative solutions.
What the Filing Says
The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the quarterly vesting on October 15, 2026 of 6.25% of restricted stock units originally granted to the Reporting Person on October 15, 2024.
Impact
This sale may affect shareholders and potential investors in Clover Health, as it reflects the company's approach to managing executive compensation and tax obligations. The transaction is mandated by the company's equity incentive plans, ensuring compliance with tax requirements without impacting Reynoso's overall ownership stake significantly.
What's Next
The filing does not say what happens next.